1.Noskin, GA, Rubin, RJ, Schentag, JJ, et al. National trends in Staphylococcus aureus infection rates: impact on economic burden and mortality over a 6-year period (1998–2003). Clin Infect Dis 2007;45:1132–1140.
2.Fluit, AC, Wielders, CL, Verhoef, J, Schmitz, FJ. Epidemiology and susceptibility of 3,051 Staphylococcus aureus isolates from 25 university hospitals participating in the European SENTRY study. J Clin Microbiol 2001;39:3727–3732.
3.Seal, JB, Moreira, B, Bethel, CD, Daum, RS. Antimicrobial resistance in Staphylococcus aureus at the University of Chicago Hospitals: a 15-year longitudinal assessment in a large university-based hospital. Infect Control Hosp Epidemiol 2003;24:403–408.
4.Shittu, AO, Lin, JAntimicrobial susceptibility patterns and characterization of clinical isolates of Staphylococcus aureus in KwaZulu-Natal province, South Africa. BMC Infect Dis 2006;6:125.
5.Kim, HB, Park, WB, Lee, KD, et al. Nationwide surveillance for Staphylococcus aureus with reduced susceptibility to vancomycin in Korea. J Clin Microbiol 2003;41:2279–2281.
6.Huang, SS, Yokoe, DS, Hinrichsen, VL, et al. Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis 2006;43:971–978.
7.Raineri, E, Crema, L, De Silvestri, A, et al. Methicillin-resistant Staphylococcus aureus control in an intensive care unit: a 10 year analysis. J Hosp Infect 2007;67:308–315.
8.Lucet, JC, Paoletti, X, Lolom, I, et al. Successful long-term program for controlling methicillin-resistant Staphylococcus aureus in intensive care units. Intensive Care Med 2005;31:1051–1057.
9.Safdar, N, Marx, J, Meyer, NA, Maki, DG. Effectiveness of preemptive barrier precautions in controlling nosocomial colonization and infection by methicillin-resistant Staphylococcus aureus in a burn unit. Am J Infect Control 2006;34:476–483.
10.Harbarth, S, Masuet-Aumatell, C, Schrenzel, J, et al. Evaluation of rapid screening and pre-emptive contact isolation for detecting and controlling methicillin-resistant Staphylococcus aureus in critical care: an interventional cohort study. Crit Care 2006;10:R25.
11.Stelfox, HT, Bates, DW, Redelmeier, DA. Safety of patients isolated for infection control. JAMA 2003;290:1899–1905.
12.Gardam, M, Brunton, J, Willey, B, McGeer, A, Low, D, Conly, J. A blinded comparison of three laboratory protocols for the identification of patients colonized with methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 2001;22:152–156.
13.Weese, JS, Rousseau, J, Traub-Dargatz, JL, Willey, BM, McGeer, AJ, Low, DE. Community-associated methicillin-resistant Staphylococcus aureus in horses and humans who work with horses. J Am Vet Med Assoc 2005;226:580–583.
14.Simor, A, Boyd, D, Louie, L, McGeer, A, Mulvey, M, Willey, B. Characterization and proposed nomenclature of epidemic strains of methicillin-resistant Staphylococcus aureus in Canada. Can Commun Dis Rep 1999;25:105–108.
15.Katz, S, Ford, AB, Moskowitz, RW, et al. Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. JAMA 1963;185:914–919.
16.Pittet, D, Hugonnet, S, Harbarth, S, et al. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Lancet 2000;356:1307–1312.
17.Dancer, SI. Importance of the environment in methicillin-resistant Staphylococcus aureus acquisition: the case for hospital cleaning. Lancet Infect Dis 2008;8:101–113.
18.Ulrich, RS, Quan, X, Choudhary, R, Joseph, A, Zimring, C. The role of the physical environment in the hospital of the 21st century: a once-in-a-lifetime opportunity. The Center for Health Design, 2004. Available at: http://www.healthdesign.org/research/reports/physical_environ.php. Accessed October 20, 2007.
19.Kibbler, CC, Quick, A, O'Neill, AM. The effect of increased bed numbers on MRSA transmission in acute medical wards. Hosp Infect 1998;39:213–219.
20.Gastmeier, P, Schwab, F, Geffers, C, Ruden, H. To isolate or not to isolate? Analysis of data from the German Nosocomial Infection Surveillance System regarding the placement of patients with methicillin-resistant Staphylococcus aureus in private rooms in intensive care units. Infect Control Hosp Epidemiol 2004;25:109–113.
21.MacKenzie, FM, Bruce, J, Struelens, MJ, Goossens, H, Mollison, J, Gould, IM, ARPAC Steering Group. Antimicrobial drug use and infection control practices associated with the prevalence of methicillin-resistant Staphylococcus aureus in European hospitals. Clin Microbiol Infect 2007;13:269–276.
22.Daeschlein, G, Assadian, O, Rangous, I, Kramer, A. Risk factors for Staphylococcus aureus nasal carriage in residents of three nursing homes in Germany. J Hosp Infect 2006;63:216–212.
23.Miyake, M, Ohbayashi, Y, Iwasaki, A, Ogawa, T, Nagahata, S. Risk factors for methicillin-resistant Staphylococcus aureus (MRSA) and use of a nasal mupirocin ointment in oral cancer inpatients. J Oral Maxillofac Surg 2007;65:2159–2163.
24.Lederer, SR, Riedelsdorf, G, Schiffl, H. Nasal carriage of methicillin resistant Staphylococcus aureus: the prevalence, patients at risk and the effect of elimination on outcomes among outclinic haemodialysis patients. Eur J Med Res 2007;12:284–288.
25.Lucet, JC, Grenet, K, Armand-Lefevre, L, et al. High prevalence of carriage of methicillin-resistant Staphylococcus aureus at hospital admission in elderly patients: implications for infection control strategies. Infect Control Hosp Epidemiol 2005;26:121–126.
26.Eveillard, M, Ernst, C, Cuviller, S, et al. Prevalence of methicillin-resistant Staphylococcus aureus carriage at the time of admission in two acute geriatric wards. J Hosp Infect 2002;50:122–126.
27.Trick, WE, Weinstein, RA, De Marais, PL, et al. Colonization of skilled-care facility residents with antimicrobial-resistant pathogens. J Am Geriatr Soc 2001;49:270–276.
28.van Werkum, JW, Ten Berg, JM, Thijs Plokker, HW, et al. Staphylococcus aureus infection complicating percutaneous coronary interventions. Int J Cardiol 2007.
29.Fang, A, Hu, SS, Endres, N, Bradford, DS. Risk factors for infection after spinal surgery. Spine 2005;30:1460–1465.
30.Chapoutot, C, Pageaux G-P, Perrigault P-F, et al. Staphylococcus aureus nasal carriage in 104 cirrhotic and control patients: a prospective study. J Hepatol 1999;30:249–253.
31.Schleifer, SJ, Keller, SE, Shiflett, S, Benton, T, Eckholdt, H. Immune changes in alcohol-dependent patients without medical disorders. Alcohol Clin Exp Res 1999;23:1199–1206.
32.Harbarth, S, Sax, H, Fankhauser-Rodriguez, C, Schrenzel, J, Agostinho, A, Pittet, D. Evaluating the probability of previously unknown carriage of MRSA at hospital admission. Am J Med 2006;119:275.
33.Aizen, E, Ljubuncic, Z, Ljubuncic, P, Aizen, I, Potasman, I. Risk factors for methicillin-resistant Staphylococcus aureus colonization in a geriatric rehabilitation hospital. J Gerontol A Biol Sci Med Sci 2007;62:1152–1156.
34.Weber, SG, Gold, HS, Hooper, DC, Karchmer, AW, Carmeli, Y. Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients. Emerg Infect Dis 2003;9:1415–1422.
35.MacDougall, C, Harpe, SE, Powel, JP, Johnson, CK, Edmond, MB, Polke, RE. Pseudomonas aeruginosa, Staphylococcus aureus and fluoroquinolone use. Emerg Infect Dis 2005;11:1197–1204.
36.Mahamat, A, MacKenzie, FM, Brooker, K, Monnet, DL, Daures, JP, Gould, IM. Impact of infection control interventions and antibiotic use on hospital MRSA: a multivariate interrupted time-series analysis. Int J Antimi-crob Agents 2007;30:169–176.
37.Bisognano, C, Vaudaux, P, Rohner, P, Lew, DP, Hooper, DC. Induction of fibronectin-binding proteins and increased adhesion of quinolone-resistant Staphylococcus aureus by subinhibitory levels of ciprofloxacin. Antimicrob Agents Chemother 2000;44:1428–1437.
38.Muto, CA, Pokrywka, M, Shutt, K, et al. A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect Control Hosp Epidemiol 2005;26:273–280.
39.Valiquette, L, Cossette, B, Garant, MP, Diab, H, Pépin, J. Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile-associated disease caused by the hypervirulent NAP 1/027 strain. Clin Infect Dis 2007;45(Suppl 2):S112–S121.
40.MacDougall, C, Polk, RE. Antimicrobial stewardship programs in health care systems. Clin Micro Rev 2005;18:638–656.